Lateralization of hippocampal nitric oxide mediator system in people with Alzheimer disease, multi-infarct dementia and schizophrenia

Neurochemistry International

Volumn 53, Issue 5, 2008, Pages 118-125

  Krištofiková, Zdena ^a   Kozmiková, Iryna ^a   Hovorková, Petra ^a   Říčný, Jan ^a   Zach, Petr ^a   Majer, Emmerich ^b   Klaschka, Jan ^a   Řípová, Daniela ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^b Patol sro ^*  (Czech Republic)

Author keywords

Dementias; Hippocampal lateralization; Nitric oxide synthases; Planum temporale; Psychosis

Indexed keywords

ARGININE; CITRULLINE; ENDOTHELIAL SYNTHETASE; GLUTAMIC ACID; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; SYNTHETASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BRAIN LEVEL; BRAIN TISSUE; CORRELATION ANALYSIS; ENZYME ACTIVITY; HEMISPHERIC DOMINANCE; HIPPOCAMPUS; HUMAN; MULTIINFARCT DEMENTIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; VOLUMETRY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ARGININE; CITRULLINE; DEMENTIA, MULTI-INFARCT; FEMALE; FUNCTIONAL LATERALITY; GLUTAMINE; HIPPOCAMPUS; HUMANS; ISOENZYMES; MALE; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 52249111602     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2008.06.009     Document Type: Article

References (47)

1. Baba H., Suzuki T., Arai H., and Emson P.C. Expression of nNOS and soluble guanylate cyclase in schizophrenic brain. Neuroreport 15 (2004) 677-680
2. Bernstein H.G., Stanarius A., Baumann B., Henning H., Krell D., Danos P., Falkai P., and Bogerts B. Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 83 (1998) 867-875
3. Bernstein H.G., Grecksch G., Becker A., Höllt V., and Bogerts B. Cellular changes in rat brain areas associated with neonatal hippocampal damage. Neuroreport 10 (1999) 2307-2311
4. Blum-Degen D., Heinemann T., Lan J., Pedersen V., Leblhuber F., Paulus W., Riederer P., and Gerlach M. Characterization and regional distribution of nitric oxide synthase in the human brain during normal aging. Brain Res. 834 (1999) 128-135
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
6. Connelly L., Madhani M., and Hobbs A.J. Resistance to endotoxic shock in endothelial nitric-oxide synthase (eNOS) knock-out mice. J. Biol. Chem. 280 (2005) 10040-10046
7. Das I., Khan N.S., Puri B.K., Sooranna S.R., de Belleroche J., and Hirsch S.R. Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain. Biochem. Biophys. Res. Commun. 212 (1995) 375-380
8. Das I., Khan N.S., Puri B.K., and Hirsch S.R. Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide production. Neurosci. Lett. 215 (1996) 209-211
9. Das I., Ramchand C.N., Gliddon A., and Hirsch S.R. Nitric oxide, free radicals and polyamines may have a role in the membrane pathology of schizophrenia. Neuropsychobiology 37 (1998) 65-67
10. de la Monte S.M., Sohn Y.K., Etienne D., Kraft J., and Wands J.R. Role of aberrant nitric oxide synthase-3 expression in cerebrovascular degeneration and vascular- mediated injury in Alzheimer's disease. Ann. N. Y. Acad. Sci. 903 (2000) 61-71
11. Dean B., and Hussain T. Studies on dopaminergic and GABAergic markers in striatum reveal a decrease in the dopamine transporter in schizophrenia. Schizophr. Res. 52 (2001) 107-114
12. Dean B., Hussain T., Hayes W., Scarr E., Kitsoulis S., Hill C., Opeskin K., and Copolov D.L. Changes in serotonin 2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex. J. Neurochem. 72 (1999) 1593-1599
13. Doyle C.A., and Slater P. Application of (3H)l-N(G)-nitro-arginine labelling to measure cerebellar nitric oxide synthase in patients with schizophrenia. Neurosci. Lett. 202 (1995) 49-52
14. Girault J.A., and Greengard P. Principles of signal transduction. In: Charney D.S., Nestler E.J., and Bunney B.S. (Eds). Neurobiology of Mental Illness (1999), Oxford University Press, Oxford 37-60
15. Graser T.A., Godel H.G., Albers S., Földi P., and Fürst P. An ultra rapid and sensitive high-performance liquid chromatographic method for determination of tissue and plasma free amino acids. Anal. Biochem. 151 (1985) 142-152
16. Guix F.X., Uribesalgo I., Coma M., and Muñoz F.J. The physiology and pathophysiology of nitric oxide in the brain. Prog. Neurobiol. 76 (2005) 126-152
17. Karson C.N., Griffin W.S., Mrak R.E., Husain M., Dawson T.M., Snyder S.H., Moore N.C., and Sturner W.Q. Nitric oxide synthase (NOS) in schizophrenia: increases in cerebellar vermis. J. Mol. Neurosci. 27 (1996) 275-284
18. Klessinger S., and Christ B. Axial structures control laterality in the distribution pattern of endothelial cells. Anat. Embryol. 193 (1996) 319-330
19. Knecht S., Dräger B., Deppe M., Bobe L., Lohmann H., Flöel A., Ringelstein E.B., and Henningsen H. Handedness and hemispheric language dominance in healthy humans. Brain 123 (2000) 2512-2518
20. Krištofiková Z., Fales E., Majer E., and Klaschka J. (3H)Hemicholinium-3 binding sites in postmortem brains of human patients with Alzheimer's disease and multi-infarct dementia. Exp. Gerontol. 30 (1995) 125-136
21. Kuiper M.A., Teerlink T., Visser J.J., Bergmans P.L.M., Scheltens P., and Wolters E.C. l-Glutamate, l-arginine and l-citrulline levels in cerebrospinal fluid of Parkinson disease, multiple system atrophy, and Alzheimer's disease patients. J. Neural Transm. 107 (2000) 183-189
22. Lahiri D.K., Chen D., Ge Y.W., Farlow M., Kotwal G., Kanthasamy A., Ingram D.K., and Greig N.H. Does nitric oxide synthase contribute to the pathogenesis of Alzheimer's disease? Effects of β-amyloid deposition on NOS in transgenic mouse brain with AD pathology. Ann. N. Y. Acad. Sci. 1010 (2003) 639-642
23. Lauer M., Johannes S., Fritzen S., Senitz D., Riederer P., and Reif A. Morphological abnormalities in nitric-oxide-synthase-positive striatal interneurons of schizophrenic patients. Neuropsychobiology 52 (2005) 111-117
24. Lowe S.L., Bowen D.M., Francis P.T., and Neary D. Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease. Neuroscience 38 (1990) 571-577
25. Lüth H., Holzer M., Gärtner U., Staufenbiel M., and Arendt T. Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's diseases, in APP23 transgenic mice and after experimental brain lesions in rat. Brain Res. 913 (2001) 57-67
26. Maarsingh H., Leusink J., Zaagsma J., and Meurs H. Role of the l-citrulline/l-arginine cycle in iNANC nerve-mediated nitric oxide production and airway smooth muscle relaxation in allergic asthma. Eur. J. Pharmacol. 546 (2006) 171-176
27. Matsuzaki S., and Tohyama M. Molecular mechanism of schizophrenia with reference to disrupted-in-schizophrenia 1 (DISC1). Neurochem. Int. 51 (2007) 165-172
28. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., and Berg L. The consortium to establish a registry for Alzheimer's disease (CERAD). Neurology 41 (1991) 479-486
29. Molina J.A., Jiménez-Jiménez F.J., Ortí-Pareja M., and Navarro J.A. The role of nitric oxide in neurodegeneration. Drugs Aging 12 (1998) 251-259
30. Peterson G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83 (1977) 346-356
31. Pfluger T., Weil S., Weis S., Vollmar C., Heiss D., Egger J., Scheck R., and Hahn K. Normative volumetric data of the developing hippocampus in children based on magnetic resonance imaging. Epilepsia 40 (1999) 414-423
32. Ramirez J., Garnica R., Boll M.C., Montes S., and Rios C. Low concentration of nitrite and nitrate in the cerebrospinal fluid from schizophrenic patients: a pilot study. Schizophr. Res. 68 (2004) 357-361
33. Ramírez M., Prieto I., Vives F., de Gasparo M., and Alba F. Neuropeptides, neuropeptidases and brain asymmetry. Curr. Protein Pept. Sci. 5 (2004) 497-506
34. Rao C.R. Linear Statistical Inference and its Application (1973), John Wiley & Sons, Inc., New York
35. Selley M.L. Increased concentrations of homocysteine and asymmetric dymethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease. Neurobiol. Aging 24 (2003) 903-907
36. Shirakawa O., Kitamura N., Lin X.H., Hashimoto T., and Maeda K. Abnormal neurochemical asymmetry in the temporal lobe of schizophrenia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 25 (2001) 867-877
37. Shirakura T., Han F., Shiota N., Moriguchi S., Kasahara J., Sato T., Shirasaki Y., and Fukunaga K. Inhibition of nitric oxide production and protein tyrosine nitration contribute to neuroprotection by a novel calmodulin antagonist, DY-9760e, in the rat microsphere embolism. Biol. Pharm. Bull. 28 (2005) 1658-1661
38. Simmaco M., de Biase D., Barra D., and Bossa F. Automated amino acid analysis using precolumn derivatization with dansylchloride and reversed-phase high-performance liquid chromatography. J. Chromatogr. 504 (1990) 129-138
39. Syková E., and Vargová L. Extrasynaptic transmission and the diffusion parameters of the extracellular space. Neurochem. Int. 52 (2008) 5-13
40. Tarkowski E., Ringqvist A., Blennow K., Wallin A., and Wennmalm A. Intrathecal release of nitric oxide in Alzheimer's disease and vascular dementia. Dement. Geriatr. Cognit. Disord. 11 (2000) 322-326
41. Toga A.W., and Thompson P.M. Mapping brain asymmetry. Nat. Rev. Neurosci. 4 (2003) 37-48
42. Tohgi H., Abe T., Yamazaki K., Murata T., Isobe C., and Ishizaki E. The cerebrospinal fluid oxidized NO metabolites, nitrite and nitrate, in Alzheimer's disease and vascular dementia of Binswanger type and multiple small infarct type. J. Neural Transm. 105 (1998) 1283-1291
43. Veenman C.L., Lehmann J., Stöhr T., Totterdell S., Yee B., Mura A., and Feldon J. Comparisons of the densities of NADPHd reactive and nNOS immunopositive neurons in the hippocampus of three age groups of young nonhandled and handled rats. Dev. Brain Res. 114 (1999) 229-243
44. Xing G., Chavko M., Zhang L.X., Yang S., and Post R.M. Decreased calcium-dependent constitutive nitric oxide synthase (cNOS) activity in prefrontal cortex in schizophrenia and depression. Schizophr. Res. 58 (2002) 21-30
45. Yamada K., Nishiwaki K., Hattori K., Senzaki K., Nagata M., Komatsu T., Shimada Y., and Nabeshima T. No change in cerebrospinal fluid levels of nitrite, nitrate and cyclic GMP with aging. J. Neural Transm. 104 (1997) 825-831
46. Yao J.K., Leonard S., and Reddy R.D. Increased nitric oxide radicals in postmortem brain from patients with schizophrenia. Schizophr. Bull. 30 (2004) 923-934
47. Zach P., Krištofiková Z., Majer E., Selinger P., and Řípová D. Alterations in the planum temporale in patients with Alzheimer disease estimated via a new volumetric method. In: Fisher A., Hanin I., Memo M., and Stocchi F. (Eds). New Trends in Alzheimer and Parkinson Related Disorders (2005), Medimond, Bologna 171-176